Lippi Systems Limited
Lippi Systems Limited (LIPPISYS.BO) Stock Competitors & Peer Comparison
See (LIPPISYS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LIPPISYS.BO | ₹73.81 | +4.99% | 516.7M | 12.51 | ₹5.90 | N/A |
| CUMMINSIND.BO | ₹5,361.30 | -0.45% | 1.5T | 66.12 | ₹81.08 | +1.00% |
| CUMMINSIND.NS | ₹5,353.00 | -0.69% | 1.5T | 66.21 | ₹80.85 | +1.00% |
| BHEL.BO | ₹408.55 | +0.06% | 1.4T | 89.20 | ₹4.58 | +0.12% |
| BHEL.NS | ₹408.55 | +0.10% | 1.4T | 88.62 | ₹4.61 | +0.12% |
| ABB.NS | ₹6,689.50 | +1.39% | 1.4T | 91.24 | ₹73.32 | +0.59% |
| ABB.BO | ₹6,688.85 | +1.34% | 1.4T | 80.22 | ₹83.38 | +0.59% |
| SIEMENS.BO | ₹3,812.05 | +2.34% | 1.4T | 80.47 | ₹47.37 | N/A |
| SIEMENS.NS | ₹3,811.70 | +2.45% | 1.4T | 80.67 | ₹47.25 | N/A |
| THERMAX.NS | ₹4,454.60 | -2.63% | 501.8B | 69.58 | ₹64.02 | +0.31% |
Stock Comparison
LIPPISYS.BO vs CUMMINSIND.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, CUMMINSIND.BO has a market cap of 1.5T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while CUMMINSIND.BO trades at ₹5,361.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas CUMMINSIND.BO's P/E ratio is 66.12. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to CUMMINSIND.BO's ROE of +0.30%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to CUMMINSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check CUMMINSIND.BO's competition here
LIPPISYS.BO vs CUMMINSIND.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, CUMMINSIND.NS has a market cap of 1.5T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while CUMMINSIND.NS trades at ₹5,353.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas CUMMINSIND.NS's P/E ratio is 66.21. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to CUMMINSIND.NS's ROE of +0.30%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to CUMMINSIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check CUMMINSIND.NS's competition here
LIPPISYS.BO vs BHEL.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, BHEL.BO has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while BHEL.BO trades at ₹408.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas BHEL.BO's P/E ratio is 89.20. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to BHEL.BO's ROE of +0.06%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to BHEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check BHEL.BO's competition here
LIPPISYS.BO vs BHEL.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, BHEL.NS has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while BHEL.NS trades at ₹408.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas BHEL.NS's P/E ratio is 88.62. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to BHEL.NS's ROE of +0.06%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to BHEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check BHEL.NS's competition here
LIPPISYS.BO vs ABB.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ABB.NS has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ABB.NS trades at ₹6,689.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ABB.NS's P/E ratio is 91.24. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ABB.NS's ROE of +0.41%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ABB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ABB.NS's competition here
LIPPISYS.BO vs ABB.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ABB.BO has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ABB.BO trades at ₹6,688.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ABB.BO's P/E ratio is 80.22. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ABB.BO's ROE of +0.41%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ABB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ABB.BO's competition here
LIPPISYS.BO vs SIEMENS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SIEMENS.BO has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SIEMENS.BO trades at ₹3,812.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SIEMENS.BO's P/E ratio is 80.47. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SIEMENS.BO's ROE of +0.13%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SIEMENS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SIEMENS.BO's competition here
LIPPISYS.BO vs SIEMENS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SIEMENS.NS has a market cap of 1.4T. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SIEMENS.NS trades at ₹3,811.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SIEMENS.NS's P/E ratio is 80.67. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SIEMENS.NS's ROE of +0.13%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SIEMENS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SIEMENS.NS's competition here
LIPPISYS.BO vs THERMAX.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, THERMAX.NS has a market cap of 501.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while THERMAX.NS trades at ₹4,454.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas THERMAX.NS's P/E ratio is 69.58. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to THERMAX.NS's ROE of +0.14%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to THERMAX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check THERMAX.NS's competition here
LIPPISYS.BO vs THERMAX.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, THERMAX.BO has a market cap of 501.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while THERMAX.BO trades at ₹4,453.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas THERMAX.BO's P/E ratio is 73.75. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to THERMAX.BO's ROE of +0.14%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to THERMAX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check THERMAX.BO's competition here
LIPPISYS.BO vs VOLTAS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, VOLTAS.NS has a market cap of 419.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while VOLTAS.NS trades at ₹1,268.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas VOLTAS.NS's P/E ratio is 111.92. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to VOLTAS.NS's ROE of +0.06%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to VOLTAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check VOLTAS.NS's competition here
LIPPISYS.BO vs VOLTAS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, VOLTAS.BO has a market cap of 419.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while VOLTAS.BO trades at ₹1,267.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas VOLTAS.BO's P/E ratio is 83.40. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to VOLTAS.BO's ROE of +0.06%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to VOLTAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check VOLTAS.BO's competition here
LIPPISYS.BO vs GET&D.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GET&D.NS has a market cap of 397.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GET&D.NS trades at ₹1,552.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GET&D.NS's P/E ratio is 100.73. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GET&D.NS's ROE of +0.27%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GET&D.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GET&D.NS's competition here
LIPPISYS.BO vs AIAENG.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, AIAENG.BO has a market cap of 373.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while AIAENG.BO trades at ₹4,001.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas AIAENG.BO's P/E ratio is 32.11. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to AIAENG.BO's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to AIAENG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check AIAENG.BO's competition here
LIPPISYS.BO vs AIAENG.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, AIAENG.NS has a market cap of 372.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while AIAENG.NS trades at ₹3,994.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas AIAENG.NS's P/E ratio is 32.04. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to AIAENG.NS's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to AIAENG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check AIAENG.NS's competition here
LIPPISYS.BO vs BLUESTARCO.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, BLUESTARCO.BO has a market cap of 340.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while BLUESTARCO.BO trades at ₹1,657.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas BLUESTARCO.BO's P/E ratio is 68.89. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to BLUESTARCO.BO's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to BLUESTARCO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check BLUESTARCO.BO's competition here
LIPPISYS.BO vs BLUESTARCO.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, BLUESTARCO.NS has a market cap of 340.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while BLUESTARCO.NS trades at ₹1,657.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas BLUESTARCO.NS's P/E ratio is 64.56. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to BLUESTARCO.NS's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to BLUESTARCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check BLUESTARCO.NS's competition here
LIPPISYS.BO vs MTARTECH.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, MTARTECH.BO has a market cap of 248.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while MTARTECH.BO trades at ₹8,083.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas MTARTECH.BO's P/E ratio is 265.02. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to MTARTECH.BO's ROE of +0.12%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to MTARTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check MTARTECH.BO's competition here
LIPPISYS.BO vs MTARTECH.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, MTARTECH.NS has a market cap of 248.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while MTARTECH.NS trades at ₹8,075.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas MTARTECH.NS's P/E ratio is 264.16. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to MTARTECH.NS's ROE of +0.12%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to MTARTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check MTARTECH.NS's competition here
LIPPISYS.BO vs KIRLOSENG.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLOSENG.NS has a market cap of 242.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLOSENG.NS trades at ₹1,671.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLOSENG.NS's P/E ratio is 42.76. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLOSENG.NS's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLOSENG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLOSENG.NS's competition here
LIPPISYS.BO vs KIRLOSENG.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLOSENG.BO has a market cap of 242.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLOSENG.BO trades at ₹1,669.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLOSENG.BO's P/E ratio is 42.81. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLOSENG.BO's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLOSENG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLOSENG.BO's competition here
LIPPISYS.BO vs TRITURBINE.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TRITURBINE.BO has a market cap of 224.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TRITURBINE.BO trades at ₹706.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TRITURBINE.BO's P/E ratio is 64.15. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TRITURBINE.BO's ROE of +0.27%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TRITURBINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TRITURBINE.BO's competition here
LIPPISYS.BO vs TRITURBINE.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TRITURBINE.NS has a market cap of 224.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TRITURBINE.NS trades at ₹706.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TRITURBINE.NS's P/E ratio is 64.09. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TRITURBINE.NS's ROE of +0.27%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TRITURBINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TRITURBINE.NS's competition here
LIPPISYS.BO vs KAYNES.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KAYNES.BO has a market cap of 222.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KAYNES.BO trades at ₹3,322.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KAYNES.BO's P/E ratio is 61.17. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KAYNES.BO's ROE of +0.10%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KAYNES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KAYNES.BO's competition here
LIPPISYS.BO vs KAYNES.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KAYNES.NS has a market cap of 222.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KAYNES.NS trades at ₹3,321.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KAYNES.NS's P/E ratio is 60.82. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KAYNES.NS's ROE of +0.10%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KAYNES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KAYNES.NS's competition here
LIPPISYS.BO vs TDPOWERSYS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TDPOWERSYS.NS has a market cap of 202.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TDPOWERSYS.NS trades at ₹1,295.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TDPOWERSYS.NS's P/E ratio is 84.81. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TDPOWERSYS.NS's ROE of +0.25%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TDPOWERSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TDPOWERSYS.NS's competition here
LIPPISYS.BO vs TDPOWERSYS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TDPOWERSYS.BO has a market cap of 202.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TDPOWERSYS.BO trades at ₹1,294.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TDPOWERSYS.BO's P/E ratio is 84.96. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TDPOWERSYS.BO's ROE of +0.25%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TDPOWERSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TDPOWERSYS.BO's competition here
LIPPISYS.BO vs LAXMIMACH.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LAXMIMACH.BO has a market cap of 185.2B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LAXMIMACH.BO trades at ₹17,338.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LAXMIMACH.BO's P/E ratio is 63.86. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LAXMIMACH.BO's ROE of +0.15%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LAXMIMACH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LAXMIMACH.BO's competition here
LIPPISYS.BO vs LAXMIMACH.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LAXMIMACH.NS has a market cap of 185.1B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LAXMIMACH.NS trades at ₹17,324.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LAXMIMACH.NS's P/E ratio is 63.45. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LAXMIMACH.NS's ROE of +0.15%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LAXMIMACH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LAXMIMACH.NS's competition here
LIPPISYS.BO vs ELGIEQUIP.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ELGIEQUIP.BO has a market cap of 176.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ELGIEQUIP.BO trades at ₹560.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ELGIEQUIP.BO's P/E ratio is 43.95. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ELGIEQUIP.BO's ROE of +0.22%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ELGIEQUIP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ELGIEQUIP.BO's competition here
LIPPISYS.BO vs ELGIEQUIP.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ELGIEQUIP.NS has a market cap of 176.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ELGIEQUIP.NS trades at ₹560.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ELGIEQUIP.NS's P/E ratio is 43.86. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ELGIEQUIP.NS's ROE of +0.22%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ELGIEQUIP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ELGIEQUIP.NS's competition here
LIPPISYS.BO vs JYOTICNC.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, JYOTICNC.NS has a market cap of 151.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while JYOTICNC.NS trades at ₹668.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas JYOTICNC.NS's P/E ratio is 42.79. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to JYOTICNC.NS's ROE of +0.21%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to JYOTICNC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check JYOTICNC.NS's competition here
LIPPISYS.BO vs LMW.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LMW.NS has a market cap of 151.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LMW.NS trades at ₹14,180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LMW.NS's P/E ratio is 116.02. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LMW.NS's ROE of +0.05%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LMW.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LMW.NS's competition here
LIPPISYS.BO vs LMW.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LMW.BO has a market cap of 151.1B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LMW.BO trades at ₹14,145.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LMW.BO's P/E ratio is 115.71. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LMW.BO's ROE of +0.15%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LMW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LMW.BO's competition here
LIPPISYS.BO vs KSB.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KSB.BO has a market cap of 142.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KSB.BO trades at ₹820.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KSB.BO's P/E ratio is 55.17. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KSB.BO's ROE of +0.00%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KSB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KSB.BO's competition here
LIPPISYS.BO vs KSB.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KSB.NS has a market cap of 142.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KSB.NS trades at ₹819.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KSB.NS's P/E ratio is 55.31. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KSB.NS's ROE of +0.00%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KSB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KSB.NS's competition here
LIPPISYS.BO vs INGERRAND.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, INGERRAND.NS has a market cap of 141.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while INGERRAND.NS trades at ₹4,477.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas INGERRAND.NS's P/E ratio is 54.62. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to INGERRAND.NS's ROE of +0.41%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to INGERRAND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check INGERRAND.NS's competition here
LIPPISYS.BO vs INGERRAND.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, INGERRAND.BO has a market cap of 140.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while INGERRAND.BO trades at ₹4,464.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas INGERRAND.BO's P/E ratio is 53.31. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to INGERRAND.BO's ROE of +0.41%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to INGERRAND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check INGERRAND.BO's competition here
LIPPISYS.BO vs AZAD.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, AZAD.NS has a market cap of 131.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while AZAD.NS trades at ₹2,039.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas AZAD.NS's P/E ratio is 98.82. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to AZAD.NS's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to AZAD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check AZAD.NS's competition here
LIPPISYS.BO vs INOXINDIA.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, INOXINDIA.NS has a market cap of 131.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while INOXINDIA.NS trades at ₹1,448.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas INOXINDIA.NS's P/E ratio is 51.25. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to INOXINDIA.NS's ROE of +0.27%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to INOXINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check INOXINDIA.NS's competition here
LIPPISYS.BO vs KIRLOSBROS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLOSBROS.NS has a market cap of 126.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLOSBROS.NS trades at ₹1,597.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLOSBROS.NS's P/E ratio is 33.97. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLOSBROS.NS's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLOSBROS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLOSBROS.NS's competition here
LIPPISYS.BO vs KIRLOSBROS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLOSBROS.BO has a market cap of 126.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLOSBROS.BO trades at ₹1,597.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLOSBROS.BO's P/E ratio is 32.32. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLOSBROS.BO's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLOSBROS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLOSBROS.BO's competition here
LIPPISYS.BO vs TEGA.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TEGA.BO has a market cap of 120.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TEGA.BO trades at ₹1,604.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TEGA.BO's P/E ratio is 53.37. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TEGA.BO's ROE of +0.15%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TEGA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TEGA.BO's competition here
LIPPISYS.BO vs TEGA.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TEGA.NS has a market cap of 120.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TEGA.NS trades at ₹1,603.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TEGA.NS's P/E ratio is 53.17. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TEGA.NS's ROE of +0.15%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TEGA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TEGA.NS's competition here
LIPPISYS.BO vs ELECON.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ELECON.BO has a market cap of 119.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ELECON.BO trades at ₹533.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ELECON.BO's P/E ratio is 35.11. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ELECON.BO's ROE of +0.16%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ELECON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ELECON.BO's competition here
LIPPISYS.BO vs ELECON.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ELECON.NS has a market cap of 119.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ELECON.NS trades at ₹533.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ELECON.NS's P/E ratio is 35.15. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ELECON.NS's ROE of +0.16%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ELECON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ELECON.NS's competition here
LIPPISYS.BO vs KIRLPNU.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLPNU.BO has a market cap of 104.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLPNU.BO trades at ₹1,607.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLPNU.BO's P/E ratio is 40.86. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLPNU.BO's ROE of +0.22%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLPNU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLPNU.BO's competition here
LIPPISYS.BO vs KIRLPNU.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KIRLPNU.NS has a market cap of 104.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KIRLPNU.NS trades at ₹1,607.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KIRLPNU.NS's P/E ratio is 40.88. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KIRLPNU.NS's ROE of +0.22%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KIRLPNU.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KIRLPNU.NS's competition here
LIPPISYS.BO vs DIACABS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, DIACABS.BO has a market cap of 102B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while DIACABS.BO trades at ₹193.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas DIACABS.BO's P/E ratio is 97.73. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to DIACABS.BO's ROE of -0.12%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to DIACABS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check DIACABS.BO's competition here
LIPPISYS.BO vs DIACABS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, DIACABS.NS has a market cap of 102B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while DIACABS.NS trades at ₹193.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas DIACABS.NS's P/E ratio is 97.24. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to DIACABS.NS's ROE of -0.12%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to DIACABS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check DIACABS.NS's competition here
LIPPISYS.BO vs VESUVIUS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, VESUVIUS.BO has a market cap of 95.2B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while VESUVIUS.BO trades at ₹469.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas VESUVIUS.BO's P/E ratio is 36.59. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to VESUVIUS.BO's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to VESUVIUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check VESUVIUS.BO's competition here
LIPPISYS.BO vs VESUVIUS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, VESUVIUS.NS has a market cap of 94.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while VESUVIUS.NS trades at ₹466.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas VESUVIUS.NS's P/E ratio is 36.36. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to VESUVIUS.NS's ROE of +0.17%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to VESUVIUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check VESUVIUS.NS's competition here
LIPPISYS.BO vs LLOYDSENGG.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LLOYDSENGG.NS has a market cap of 93.2B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LLOYDSENGG.NS trades at ₹69.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LLOYDSENGG.NS's P/E ratio is 46.56. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LLOYDSENGG.NS's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LLOYDSENGG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LLOYDSENGG.NS's competition here
LIPPISYS.BO vs LLOYDSENGG.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LLOYDSENGG.BO has a market cap of 93.2B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LLOYDSENGG.BO trades at ₹69.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LLOYDSENGG.BO's P/E ratio is 46.55. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LLOYDSENGG.BO's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LLOYDSENGG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LLOYDSENGG.BO's competition here
LIPPISYS.BO vs ISGEC.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ISGEC.BO has a market cap of 79.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ISGEC.BO trades at ₹1,079.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ISGEC.BO's P/E ratio is 23.93. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ISGEC.BO's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ISGEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ISGEC.BO's competition here
LIPPISYS.BO vs ISGEC.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ISGEC.NS has a market cap of 79.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ISGEC.NS trades at ₹1,078.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ISGEC.NS's P/E ratio is 23.87. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ISGEC.NS's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ISGEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ISGEC.NS's competition here
LIPPISYS.BO vs SHAKTIPUMP.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SHAKTIPUMP.NS has a market cap of 62.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SHAKTIPUMP.NS trades at ₹505.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SHAKTIPUMP.NS's P/E ratio is 24.07. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SHAKTIPUMP.NS's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SHAKTIPUMP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SHAKTIPUMP.NS's competition here
LIPPISYS.BO vs SHAKTIPUMP.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SHAKTIPUMP.BO has a market cap of 62.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SHAKTIPUMP.BO trades at ₹505.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SHAKTIPUMP.BO's P/E ratio is 24.05. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SHAKTIPUMP.BO's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SHAKTIPUMP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SHAKTIPUMP.BO's competition here
LIPPISYS.BO vs DIAPOWER.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, DIAPOWER.NS has a market cap of 52.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while DIAPOWER.NS trades at ₹195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas DIAPOWER.NS's P/E ratio is -1.78. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to DIAPOWER.NS's ROE of +0.05%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to DIAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check DIAPOWER.NS's competition here
LIPPISYS.BO vs LSIL.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LSIL.NS has a market cap of 52.1B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LSIL.NS trades at ₹48.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LSIL.NS's P/E ratio is 130.41. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LSIL.NS's ROE of +0.22%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LSIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LSIL.NS's competition here
LIPPISYS.BO vs TEXRAIL.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TEXRAIL.BO has a market cap of 44.1B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TEXRAIL.BO trades at ₹108.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TEXRAIL.BO's P/E ratio is 22.39. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TEXRAIL.BO's ROE of +0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TEXRAIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TEXRAIL.BO's competition here
LIPPISYS.BO vs TEXRAIL.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, TEXRAIL.NS has a market cap of 44B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while TEXRAIL.NS trades at ₹108.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas TEXRAIL.NS's P/E ratio is 22.31. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to TEXRAIL.NS's ROE of +0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to TEXRAIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check TEXRAIL.NS's competition here
LIPPISYS.BO vs WPIL.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, WPIL.BO has a market cap of 41.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while WPIL.BO trades at ₹425.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas WPIL.BO's P/E ratio is 34.84. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to WPIL.BO's ROE of +0.10%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to WPIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check WPIL.BO's competition here
LIPPISYS.BO vs ANUP.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ANUP.NS has a market cap of 39.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ANUP.NS trades at ₹1,977.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ANUP.NS's P/E ratio is 34.47. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ANUP.NS's ROE of +0.19%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ANUP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ANUP.NS's competition here
LIPPISYS.BO vs ANUP.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ANUP.BO has a market cap of 39.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ANUP.BO trades at ₹1,976.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ANUP.BO's P/E ratio is 34.44. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ANUP.BO's ROE of +0.19%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ANUP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ANUP.BO's competition here
LIPPISYS.BO vs GREAVESCOT.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GREAVESCOT.NS has a market cap of 39.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GREAVESCOT.NS trades at ₹169.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GREAVESCOT.NS's P/E ratio is 37.24. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GREAVESCOT.NS's ROE of +0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GREAVESCOT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GREAVESCOT.NS's competition here
LIPPISYS.BO vs GREAVESCOT.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GREAVESCOT.BO has a market cap of 39.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GREAVESCOT.BO trades at ₹169.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GREAVESCOT.BO's P/E ratio is 38.07. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GREAVESCOT.BO's ROE of +0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GREAVESCOT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GREAVESCOT.BO's competition here
LIPPISYS.BO vs GMMPFAUDLR.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GMMPFAUDLR.BO has a market cap of 36.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GMMPFAUDLR.BO trades at ₹807.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GMMPFAUDLR.BO's P/E ratio is 205.41. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GMMPFAUDLR.BO's ROE of -0.02%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GMMPFAUDLR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GMMPFAUDLR.BO's competition here
LIPPISYS.BO vs GMMPFAUDLR.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GMMPFAUDLR.NS has a market cap of 36.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GMMPFAUDLR.NS trades at ₹807.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GMMPFAUDLR.NS's P/E ratio is 205.37. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GMMPFAUDLR.NS's ROE of +0.06%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GMMPFAUDLR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GMMPFAUDLR.NS's competition here
LIPPISYS.BO vs SHANTIGEAR.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SHANTIGEAR.BO has a market cap of 33.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SHANTIGEAR.BO trades at ₹441.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SHANTIGEAR.BO's P/E ratio is 44.23. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SHANTIGEAR.BO's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SHANTIGEAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SHANTIGEAR.BO's competition here
LIPPISYS.BO vs SHANTIGEAR.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SHANTIGEAR.NS has a market cap of 33.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SHANTIGEAR.NS trades at ₹440.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SHANTIGEAR.NS's P/E ratio is 44.03. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SHANTIGEAR.NS's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SHANTIGEAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SHANTIGEAR.NS's competition here
LIPPISYS.BO vs SGLTL.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SGLTL.NS has a market cap of 27.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SGLTL.NS trades at ₹137.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SGLTL.NS's P/E ratio is 38.46. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SGLTL.NS's ROE of +0.10%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SGLTL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SGLTL.NS's competition here
LIPPISYS.BO vs SETL.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, SETL.NS has a market cap of 26.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while SETL.NS trades at ₹132.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas SETL.NS's P/E ratio is 33.15. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to SETL.NS's ROE of +0.08%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to SETL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check SETL.NS's competition here
LIPPISYS.BO vs KLBRENG-B.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KLBRENG-B.BO has a market cap of 25.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KLBRENG-B.BO trades at ₹478.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KLBRENG-B.BO's P/E ratio is 25.71. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KLBRENG-B.BO's ROE of +0.20%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KLBRENG-B.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KLBRENG-B.BO's competition here
LIPPISYS.BO vs WINDMACHIN.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, WINDMACHIN.BO has a market cap of 25.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while WINDMACHIN.BO trades at ₹288.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas WINDMACHIN.BO's P/E ratio is 3202.78. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to WINDMACHIN.BO's ROE of -0.00%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to WINDMACHIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check WINDMACHIN.BO's competition here
LIPPISYS.BO vs WINDMACHIN.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, WINDMACHIN.NS has a market cap of 25.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while WINDMACHIN.NS trades at ₹287.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas WINDMACHIN.NS's P/E ratio is 3197.22. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to WINDMACHIN.NS's ROE of -0.00%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to WINDMACHIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check WINDMACHIN.NS's competition here
LIPPISYS.BO vs KMEW.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, KMEW.BO has a market cap of 25.3B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while KMEW.BO trades at ₹2,066.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas KMEW.BO's P/E ratio is 73.51. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to KMEW.BO's ROE of +0.30%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to KMEW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check KMEW.BO's competition here
LIPPISYS.BO vs JASH.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, JASH.NS has a market cap of 25.2B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while JASH.NS trades at ₹399.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas JASH.NS's P/E ratio is 45.16. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to JASH.NS's ROE of +0.13%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to JASH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check JASH.NS's competition here
LIPPISYS.BO vs GMM.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, GMM.BO has a market cap of 22.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while GMM.BO trades at ₹1,563.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas GMM.BO's P/E ratio is 31.46. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to GMM.BO's ROE of -0.02%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to GMM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check GMM.BO's competition here
LIPPISYS.BO vs HLEGLAS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, HLEGLAS.BO has a market cap of 22.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while HLEGLAS.BO trades at ₹325.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas HLEGLAS.BO's P/E ratio is 33.36. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to HLEGLAS.BO's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to HLEGLAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check HLEGLAS.BO's competition here
LIPPISYS.BO vs HLEGLAS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, HLEGLAS.NS has a market cap of 22.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while HLEGLAS.NS trades at ₹324.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas HLEGLAS.NS's P/E ratio is 33.23. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to HLEGLAS.NS's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to HLEGLAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check HLEGLAS.NS's competition here
LIPPISYS.BO vs HONDAPOWER.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, HONDAPOWER.NS has a market cap of 22.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while HONDAPOWER.NS trades at ₹2,221.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas HONDAPOWER.NS's P/E ratio is 30.68. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to HONDAPOWER.NS's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to HONDAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check HONDAPOWER.NS's competition here
LIPPISYS.BO vs HONDAPOWER.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, HONDAPOWER.BO has a market cap of 22.5B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while HONDAPOWER.BO trades at ₹2,214.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas HONDAPOWER.BO's P/E ratio is 30.53. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to HONDAPOWER.BO's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to HONDAPOWER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check HONDAPOWER.BO's competition here
LIPPISYS.BO vs PIXTRANS.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, PIXTRANS.NS has a market cap of 22.1B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while PIXTRANS.NS trades at ₹1,623.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas PIXTRANS.NS's P/E ratio is 20.22. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to PIXTRANS.NS's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to PIXTRANS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check PIXTRANS.NS's competition here
LIPPISYS.BO vs PIXTRANS.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, PIXTRANS.BO has a market cap of 22B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while PIXTRANS.BO trades at ₹1,614.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas PIXTRANS.BO's P/E ratio is 20.12. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to PIXTRANS.BO's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to PIXTRANS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check PIXTRANS.BO's competition here
LIPPISYS.BO vs ADVAIT.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ADVAIT.BO has a market cap of 21.9B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ADVAIT.BO trades at ₹2,006.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ADVAIT.BO's P/E ratio is 48.31. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ADVAIT.BO's ROE of +0.23%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ADVAIT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ADVAIT.BO's competition here
LIPPISYS.BO vs NIBE.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, NIBE.BO has a market cap of 21.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while NIBE.BO trades at ₹1,452.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas NIBE.BO's P/E ratio is -302.02. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to NIBE.BO's ROE of -0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to NIBE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check NIBE.BO's competition here
LIPPISYS.BO vs JNKINDIA.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, JNKINDIA.NS has a market cap of 21.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while JNKINDIA.NS trades at ₹387.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas JNKINDIA.NS's P/E ratio is 47.21. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to JNKINDIA.NS's ROE of +0.09%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to JNKINDIA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check JNKINDIA.NS's competition here
LIPPISYS.BO vs NIBE.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, NIBE.NS has a market cap of 21.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while NIBE.NS trades at ₹1,450.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas NIBE.NS's P/E ratio is -304.09. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to NIBE.NS's ROE of -0.07%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to NIBE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check NIBE.NS's competition here
LIPPISYS.BO vs PENIND.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, PENIND.NS has a market cap of 20.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while PENIND.NS trades at ₹151.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas PENIND.NS's P/E ratio is 15.27. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to PENIND.NS's ROE of +0.13%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to PENIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check PENIND.NS's competition here
LIPPISYS.BO vs PENIND.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, PENIND.BO has a market cap of 20.4B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while PENIND.BO trades at ₹150.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas PENIND.BO's P/E ratio is 15.26. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to PENIND.BO's ROE of +0.13%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to PENIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check PENIND.BO's competition here
LIPPISYS.BO vs ADOR.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ADOR.BO has a market cap of 18.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ADOR.BO trades at ₹1,072.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ADOR.BO's P/E ratio is 22.81. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ADOR.BO's ROE of +0.16%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ADOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ADOR.BO's competition here
LIPPISYS.BO vs ADOR.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ADOR.NS has a market cap of 18.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ADOR.NS trades at ₹1,072.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ADOR.NS's P/E ratio is 22.76. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ADOR.NS's ROE of +0.16%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ADOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ADOR.NS's competition here
LIPPISYS.BO vs THEJO.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, THEJO.NS has a market cap of 17.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while THEJO.NS trades at ₹1,629.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas THEJO.NS's P/E ratio is 36.34. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to THEJO.NS's ROE of +0.16%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to THEJO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check THEJO.NS's competition here
LIPPISYS.BO vs DISAQ.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, DISAQ.BO has a market cap of 16.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while DISAQ.BO trades at ₹11,577.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas DISAQ.BO's P/E ratio is 31.65. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to DISAQ.BO's ROE of +0.19%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to DISAQ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check DISAQ.BO's competition here
LIPPISYS.BO vs LXMIATO.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, LXMIATO.BO has a market cap of 16.6B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while LXMIATO.BO trades at ₹2,483.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas LXMIATO.BO's P/E ratio is 584.15. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to LXMIATO.BO's ROE of +0.01%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to LXMIATO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check LXMIATO.BO's competition here
LIPPISYS.BO vs ADORWELD.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ADORWELD.NS has a market cap of 14.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ADORWELD.NS trades at ₹852.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ADORWELD.NS's P/E ratio is 33.22. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ADORWELD.NS's ROE of +0.18%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ADORWELD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ADORWELD.NS's competition here
LIPPISYS.BO vs ADORWELD.BO Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, ADORWELD.BO has a market cap of 14.8B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while ADORWELD.BO trades at ₹852.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas ADORWELD.BO's P/E ratio is 24.67. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to ADORWELD.BO's ROE of +0.02%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to ADORWELD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check ADORWELD.BO's competition here
LIPPISYS.BO vs JYOTISTRUC.NS Comparison May 2026
LIPPISYS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIPPISYS.BO stands at 516.7M. In comparison, JYOTISTRUC.NS has a market cap of 14.7B. Regarding current trading prices, LIPPISYS.BO is priced at ₹73.81, while JYOTISTRUC.NS trades at ₹12.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIPPISYS.BO currently has a P/E ratio of 12.51, whereas JYOTISTRUC.NS's P/E ratio is 26.19. In terms of profitability, LIPPISYS.BO's ROE is +0.20%, compared to JYOTISTRUC.NS's ROE of +0.11%. Regarding short-term risk, LIPPISYS.BO is less volatile compared to JYOTISTRUC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for LIPPISYS.BO.Check JYOTISTRUC.NS's competition here